Johan Sandin is a behavioral neuropharmacologist with significant international academic and industrial experience. He joined AstraZeneca in 2003 and has had scientific-, project- and senior managerial positions with responsibility for in vitro biology, in vivo pharmacology and biochemical biomarkers in the CNS research area
Johan Sandin research interest in vitro biology, in vivo pharmacology and biochemical biomarkers